Process Excellence and High Quality Manufacturing

Monday, November 4, 2013: 5:00 PM-7:00 PM
Capri Ballroom (Marriott Marco Island)



P37
Non-Traditional Flu Vaccine Manufacturing Facility
Erin Kinnevy1, Ian Penkala1, April Soohoo1, John Vogel1, Miriam Wattenbarger1 and Tiffany D. Rau2, (1)Chemical and Biomolecular Engineering, University of Pennsylvania, Philadelphia, PA, (2)Eli Lilly, Lake Charles, LA
P38
Real-time bioprocess monitor for on-line measurement and control
Chris Evans, ASL Analytical, Coralville, IA
P39
Production Mitigation in an Ethanol Fermentation Process
Consuelo Cruz, Research and Development, Archer Daniels Midland Company, Decatur, IL
P40
Identification and prevention of a colored product variant during recombinant protein production in E. coli
Michael W. Laird1, Wendy Lau2, Jane Gunson1 and Rick St. John3, (1)Late Stage Cell Culture - Pharma Technical Development, Genentech, Inc., South San Francisco, CA, (2)IMP Quality, Genentech, Inc., South San Francisco, CA, (3)Purification Development, Genentech, Inc., South San Francisco, CA
P41
Development of Enhanced Harvest Process Controls to Inhibit Colored Protein-Adduct Formation
Jane Gunson1, Kimberly Kaleas-Carroll2, Deepa Nadarajah2, Rick St. John3 and Michael W. Laird1, (1)Late Stage Cell Culture - Pharma Technical Development, Genentech, Inc., South San Francisco, CA, (2)Purification Development - Pharma Technical Development, Genentech, Inc., South San Francisco, CA, (3)Purification Development, Genentech, Inc., South San Francisco, CA
P42
Development of an E .coli Recombinant Protein Fermentation Process
Nitya Krishnan, Late Stage Cell Culture, Pharma Technical Development, Genentech, Inc, South San Francisco, CA and Jane Gunson, Late Stage Cell Culture - Pharma Technical Development, Genentech, Inc., South San Francisco, CA
P43
Cost-effective biocatalyst manufacture
Matthew Bycroft and Neil Triggs, Chirotech Technology Centre, Dr. Reddy's Laboratories, Cambridge, United Kingdom
See more of: Posters